Profile data is unavailable for this security.
About the company
GlucoTrack, Inc. is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is developing an implantable continuous glucose monitoring (CGM) for use by Type 1 diabetes patients as well as insulin-dependent Type 2 patients. It is developing an implantable continuous blood glucose monitor (CBGM). This product is designed to have an approximately two-year implant longevity without the requirement for any wearable components. The CBGM utilizes an intravascular approach, in which the device is implanted subcutaneously and connected to a lead that is placed directly into a blood vessel. This facilitates continuous blood glucose measurements with zero lag time. The Company is also developing the Glucotrack CBGM a companion mobile application and a cloud-based solution to provide real time, data-driven personalized tools to effectively help a user manage their diabetes and assist healthcare providers with making treatment decisions.
- Revenue in USD (TTM)0.00
- Net income in USD-12.05m
- Incorporated2010
- Employees6.00
- LocationGlucoTrack Inc301 Rt 17 North, Suite 800RUTHERFORD 07070United StatesUSA
- Phone+1 (201) 842-7715
- Fax+1 (302) 655-5049
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NLS Pharmaceutics AG | 0.00 | -6.60m | 7.72m | 3.00 | -- | -- | -- | -- | -6.72 | -6.72 | 0.00 | -9.40 | 0.00 | -- | -- | 0.00 | -380.82 | -272.62 | -- | -- | -- | -- | -- | -- | -- | -27.20 | -- | -- | -- | -- | 26.21 | -- | -- | -- |
| Alterola Biotech Inc | 0.00 | -2.06m | 7.74m | 1.00 | -- | -- | -- | -- | -0.0017 | -0.0017 | 0.00 | -0.001 | 0.00 | -- | -- | 0.00 | -32.46 | -- | -46.53 | -- | -- | -- | -- | -- | 0.0073 | -- | -- | -- | -- | -- | -14.64 | -- | -- | -- |
| Edesa Biotech Inc | 0.00 | -6.93m | 7.76m | 16.00 | -- | 2.71 | -- | -- | -2.21 | -2.21 | 0.00 | 0.8829 | 0.00 | -- | -- | 0.00 | -94.60 | -- | -128.81 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 52.28 | -- | -- | -- |
| Curative Biotechnology Inc | 0.00 | -6.02m | 7.95m | 4.00 | -- | -- | -- | -- | -0.0105 | -0.0105 | 0.00 | -0.0018 | 0.00 | -- | -- | 0.00 | -339.98 | -- | -- | -- | -- | -- | -- | -- | -- | -5.51 | -- | -- | -- | -- | -302.92 | -- | -- | -- |
| Vitro Biopharma Inc | 1.85m | -9.72m | 8.05m | 10.00 | -- | -- | -- | 4.35 | -2.18 | -2.18 | 0.4159 | -1.64 | 0.2324 | 1.58 | 24.96 | 185,140.00 | -122.00 | -- | -1,146.77 | -- | 82.88 | -- | -524.87 | -- | 0.169 | -5.37 | 5.49 | -- | -46.45 | -- | 31.01 | -- | -- | -- |
| Forte Biosciences Inc | 0.00 | -35.76m | 8.29m | 11.00 | -- | 0.4879 | -- | -- | -22.03 | -22.03 | 0.00 | 11.64 | 0.00 | -- | -- | 0.00 | -124.89 | -72.06 | -170.91 | -82.27 | -- | -- | -- | -491,850.00 | -- | -- | 0.00 | -- | -- | -- | -126.79 | -- | -46.29 | -- |
| Bioxytran Inc | 0.00 | -2.90m | 8.30m | 2.00 | -- | -- | -- | -- | -0.0188 | -0.0188 | 0.00 | -0.0132 | 0.00 | -- | -- | -- | -1,687.15 | -1,420.53 | -- | -- | -- | -- | -- | -- | -- | -17.23 | -- | -- | -- | -- | -73.71 | -- | -- | -- |
| BioCardia Inc | 428.00k | -8.56m | 8.40m | 16.00 | -- | -- | -- | 19.64 | -5.40 | -5.40 | 0.2636 | -0.9233 | 0.0923 | -- | 6.85 | 26,750.00 | -184.48 | -107.34 | -1,075.25 | -154.17 | -- | -- | -1,999.77 | -1,779.24 | -- | -- | -- | -- | -64.72 | -5.26 | 2.82 | -- | -28.89 | -- |
| Intelligent Bio Solutions Inc | 3.11m | -10.16m | 8.51m | 13.00 | -- | 0.8049 | -- | 2.73 | -39.72 | -39.72 | 2.31 | 2.41 | 0.2579 | 1.92 | 8.60 | 239,366.90 | -84.45 | -71.59 | -156.10 | -144.36 | 45.81 | -- | -327.50 | -565.48 | 1.42 | -- | 0.0592 | -- | 147.58 | 596.39 | 4.47 | -- | -- | -- |
| GlucoTrack Inc | 0.00 | -12.05m | 8.60m | 6.00 | -- | -- | -- | -- | -2.42 | -2.42 | 0.00 | -0.6004 | 0.00 | -- | -- | 0.00 | -251.32 | -94.01 | -493.89 | -142.35 | -- | -- | -- | -10,447.96 | -- | -- | -- | -- | -- | -- | -60.02 | -- | -- | -- |
| Virax Biolabs Group Ltd | 156.42k | -6.73m | 8.72m | 17.00 | -- | 1.03 | -- | 55.73 | -3.35 | -3.35 | 0.078 | 2.09 | 0.0205 | 3.51 | -- | 9,201.18 | -88.11 | -- | -91.88 | -- | 32.34 | -- | -4,308.35 | -- | 25.58 | -227.16 | 0.0418 | -- | 1,727.34 | -- | -23.38 | -- | -- | -- |
| Soligenix Inc | 494.62k | -7.04m | 9.16m | 13.00 | -- | 1.62 | -- | 18.52 | -9.58 | -9.58 | 0.6152 | 2.25 | 0.0418 | -- | 8.70 | 38,047.69 | -59.45 | -75.40 | -121.64 | -154.32 | 8.75 | 22.83 | -1,423.81 | -620.02 | -- | -- | 0.4421 | -- | -11.54 | -30.67 | 55.50 | -- | -- | -- |
| Galecto Inc | 0.00 | -21.17m | 9.22m | 13.00 | -- | 0.4192 | -- | -- | -19.33 | -19.33 | 0.00 | 16.70 | 0.00 | -- | -- | 0.00 | -57.67 | -48.46 | -72.47 | -52.36 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 37.77 | -- | -- | -- |
| Vaccinex Inc | 356.00k | -17.76m | 9.31m | 37.00 | -- | -- | -- | 26.15 | -24.59 | -24.59 | 0.3183 | -1.81 | 0.1306 | -- | 0.6742 | 9,621.62 | -651.39 | -262.29 | -- | -- | -- | -- | -4,987.92 | -4,257.17 | -- | -52.60 | -- | -- | 107.27 | -4.67 | -2.20 | -- | -22.20 | -- |
| NKGen Biotech Inc | 0.00 | -88.25m | 9.36m | 63.00 | -- | -- | -- | -- | -3.74 | -3.74 | 0.00 | -2.71 | 0.00 | -- | -- | 0.00 | -480.25 | -- | -- | -- | -- | -- | -- | -- | -- | -0.4822 | -- | -- | -100.00 | -- | -210.06 | -- | -- | -- |
| Mustang Bio Inc | 0.00 | -32.06m | 9.51m | 80.00 | -- | -- | -- | -- | -2.91 | -2.91 | 0.00 | -0.2384 | 0.00 | -- | -- | 0.00 | -170.53 | -70.02 | -727.24 | -79.98 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 33.44 | -- | -60.75 | -- |
Data as of Nov 13 2024. Currency figures normalised to GlucoTrack Inc's reporting currency: US Dollar USD
0.55%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Alerus Financial, NA (Private Banking)as of 30 Jun 2024 | 13.86k | 0.25% |
| Cetera Investment Advisers LLCas of 30 Jun 2024 | 10.00k | 0.18% |
| UBS Securities LLCas of 30 Jun 2024 | 6.09k | 0.11% |
| Citadel Securities LLCas of 30 Jun 2024 | 0.00 | 0.00% |
| Renaissance Technologies LLCas of 30 Jun 2024 | 0.00 | 0.00% |
| Sabby Management LLCas of 30 Jun 2024 | 0.00 | 0.00% |
| G1 Execution Services LLCas of 30 Jun 2024 | 0.00 | 0.00% |
| Virtue Capital Management LLCas of 30 Jun 2024 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
